Amgen's New Products Have Ample Insurance Coverage In The U.S. - Seeking Alpha
Amgen's New Products Have Ample Insurance Coverage In The U.S.
Seeking Alpha
Amgen launched at least 4 new drugs in the past 2 years to compensate for biosimilar competition against its top products. IMLYGIC, Corlanor, and BLINCYTO are well represented among the top 10 health insurers, who typically wait a full year before ...
Read more »